Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

For years, privacy-focused blockchains were seen as side projects with limited reach. That’s about to change with Zero Knowledge Proof (ZKP). Built as a privacy ...

Zero Knowledge Proof (ZKP) is built for pressure. Explore the tech and prepare for the whitelist, opening soon for early access.

With the rise in adoption of agentic AI by companies for automation and increasing complexities of the newer versions, ...

If you're an artist doing retro-style work (or you dream of getting started) and you'd like to do more with your Linux ...

New research reveals how Mayan astronomers built a precise eclipse prediction system using complex lunar mathematics.

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Prediction of crystal structures of organic molecules is a critical task in many industries, especially in pharmaceuticals ...

Within the peer analysis summary, vital metrics for Agios Pharmaceuticals, Recursion Pharmaceuticals and Apellis ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...